These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

216 related items for PubMed ID: 19304334

  • 1. Selective ablation of Notch3 in HCC enhances doxorubicin's death promoting effect by a p53 dependent mechanism.
    Giovannini C, Gramantieri L, Chieco P, Minguzzi M, Lago F, Pianetti S, Ramazzotti E, Marcu KB, Bolondi L.
    J Hepatol; 2009 May; 50(5):969-79. PubMed ID: 19304334
    [Abstract] [Full Text] [Related]

  • 2. Suppression of p53 by Notch3 is mediated by Cyclin G1 and sustained by MDM2 and miR-221 axis in hepatocellular carcinoma.
    Giovannini C, Minguzzi M, Baglioni M, Fornari F, Giannone F, Ravaioli M, Cescon M, Chieco P, Bolondi L, Gramantieri L.
    Oncotarget; 2014 Nov 15; 5(21):10607-20. PubMed ID: 25431954
    [Abstract] [Full Text] [Related]

  • 3. Notch1 signaling sensitizes tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis in human hepatocellular carcinoma cells by inhibiting Akt/Hdm2-mediated p53 degradation and up-regulating p53-dependent DR5 expression.
    Wang C, Qi R, Li N, Wang Z, An H, Zhang Q, Yu Y, Cao X.
    J Biol Chem; 2009 Jun 12; 284(24):16183-16190. PubMed ID: 19376776
    [Abstract] [Full Text] [Related]

  • 4. A novel interaction of nucleophosmin with BCL2-associated X protein regulating death evasion and drug sensitivity in human hepatoma cells.
    Lo SJ, Fan LC, Tsai YF, Lin KY, Huang HL, Wang TH, Liu H, Chen TC, Huang SF, Chang CJ, Lin YJ, Yung BY, Hsieh SY.
    Hepatology; 2013 May 12; 57(5):1893-905. PubMed ID: 23258611
    [Abstract] [Full Text] [Related]

  • 5. Hepatitis B virus X protein and hypoxia‑inducible factor-1α stimulate Notch gene expression in liver cancer cells.
    Yang SL, Ren QG, Zhang T, Pan X, Wen L, Hu JL, Yu C, He QJ.
    Oncol Rep; 2017 Jan 12; 37(1):348-356. PubMed ID: 27840976
    [Abstract] [Full Text] [Related]

  • 6. WP1130 increases doxorubicin sensitivity in hepatocellular carcinoma cells through usp9x-dependent p53 degradation.
    Liu H, Chen W, Liang C, Chen BW, Zhi X, Zhang S, Zheng X, Bai X, Liang T.
    Cancer Lett; 2015 Jun 01; 361(2):218-25. PubMed ID: 25749422
    [Abstract] [Full Text] [Related]

  • 7. MicroRNA-760 Inhibits Doxorubicin Resistance in Hepatocellular Carcinoma through Regulating Notch1/Hes1-PTEN/Akt Signaling Pathway.
    Tian T, Fu X, Lu J, Ruan Z, Nan K, Yao Y, Yang Y.
    J Biochem Mol Toxicol; 2018 Aug 01; 32(8):e22167. PubMed ID: 29968951
    [Abstract] [Full Text] [Related]

  • 8. Notch3 inhibition enhances sorafenib cytotoxic efficacy by promoting GSK3b phosphorylation and p21 down-regulation in hepatocellular carcinoma.
    Giovannini C, Baglioni M, Baron Toaldo M, Ventrucci C, D'Adamo S, Cipone M, Chieco P, Gramantieri L, Bolondi L.
    Oncotarget; 2013 Oct 01; 4(10):1618-31. PubMed ID: 24113128
    [Abstract] [Full Text] [Related]

  • 9. Aberrant Notch3 and Notch4 expression in human hepatocellular carcinoma.
    Gramantieri L, Giovannini C, Lanzi A, Chieco P, Ravaioli M, Venturi A, Grazi GL, Bolondi L.
    Liver Int; 2007 Sep 01; 27(7):997-1007. PubMed ID: 17696940
    [Abstract] [Full Text] [Related]

  • 10. Nutlin-3 cooperates with doxorubicin to induce apoptosis of human hepatocellular carcinoma cells through p53 or p73 signaling pathways.
    Zheng T, Wang J, Song X, Meng X, Pan S, Jiang H, Liu L.
    J Cancer Res Clin Oncol; 2010 Oct 01; 136(10):1597-604. PubMed ID: 20174822
    [Abstract] [Full Text] [Related]

  • 11. miR-26b enhances the sensitivity of hepatocellular carcinoma to Doxorubicin via USP9X-dependent degradation of p53 and regulation of autophagy.
    Chen E, Li E, Liu H, Zhou Y, Wen L, Wang J, Wang Y, Ye L, Liang T.
    Int J Biol Sci; 2021 Oct 01; 17(3):781-795. PubMed ID: 33767588
    [Abstract] [Full Text] [Related]

  • 12. SIRT7 regulates hepatocellular carcinoma response to therapy by altering the p53-dependent cell death pathway.
    Zhao J, Wozniak A, Adams A, Cox J, Vittal A, Voss J, Bridges B, Weinman SA, Li Z.
    J Exp Clin Cancer Res; 2019 Jun 13; 38(1):252. PubMed ID: 31196136
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Trefoil factor 3 mediation of oncogenicity and chemoresistance in hepatocellular carcinoma is AKT-BCL-2 dependent.
    You ML, Chen YJ, Chong QY, Wu MM, Pandey V, Chen RM, Liu L, Ma L, Wu ZS, Zhu T, Lobie PE.
    Oncotarget; 2017 Jun 13; 8(24):39323-39344. PubMed ID: 28445151
    [Abstract] [Full Text] [Related]

  • 15. Epigenetic silencing of BCL6B inactivates p53 signaling and causes human hepatocellular carcinoma cell resist to 5-FU.
    Li X, Yu J, Brock MV, Tao Q, Herman JG, Liang P, Guo M.
    Oncotarget; 2015 May 10; 6(13):11547-60. PubMed ID: 25909168
    [Abstract] [Full Text] [Related]

  • 16. The significance of Notch1 compared with Notch3 in high metastasis and poor overall survival in hepatocellular carcinoma.
    Zhou L, Zhang N, Song W, You N, Li Q, Sun W, Zhang Y, Wang D, Dou K.
    PLoS One; 2013 May 10; 8(2):e57382. PubMed ID: 23468978
    [Abstract] [Full Text] [Related]

  • 17. MiR-122/cyclin G1 interaction modulates p53 activity and affects doxorubicin sensitivity of human hepatocarcinoma cells.
    Fornari F, Gramantieri L, Giovannini C, Veronese A, Ferracin M, Sabbioni S, Calin GA, Grazi GL, Croce CM, Tavolari S, Chieco P, Negrini M, Bolondi L.
    Cancer Res; 2009 Jul 15; 69(14):5761-7. PubMed ID: 19584283
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Activated Notch signaling augments cell growth in hepatocellular carcinoma via up-regulating the nuclear receptor NR4A2.
    Zhu B, Sun L, Luo W, Li M, Coy DH, Yu L, Yu W.
    Oncotarget; 2017 Apr 04; 8(14):23289-23302. PubMed ID: 28423575
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.